114 related articles for article (PubMed ID: 3299308)
21. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
[TBL] [Abstract][Full Text] [Related]
22. Effect of intravenous ketanserin on arterial and intracranial pressures in patients with systemic hypertension following intracerebral haemorrhage.
Kay R; Poon WS; Nicholls MG
J Hum Hypertens; 1993 Aug; 7(4):369-71. PubMed ID: 8410928
[TBL] [Abstract][Full Text] [Related]
23. Comparison of ketanserin and metoprolol in the treatment of essential hypertension.
Sheps SG; Schirger A; Zachariah PK; Fisher LD; Spiekerman RE; Araas FJ; Collins JB; Agerter DC
Arch Intern Med; 1987 Feb; 147(2):291-6. PubMed ID: 3545116
[TBL] [Abstract][Full Text] [Related]
24. [Clinical application of serotonin antagonists in the treatment of hypertension].
Deguchi F; Saito T; Inagaki Y
Nihon Rinsho; 1989 Sep; 47(9):2058-63. PubMed ID: 2593279
[No Abstract] [Full Text] [Related]
25. Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats.
Kalkman HO; Timmermans PB; Van Zwieten PA
J Pharmacol Exp Ther; 1982 Jul; 222(1):227-31. PubMed ID: 6283070
[No Abstract] [Full Text] [Related]
26. Effects of a new serotonin antagonist, ketanserin, in experimental and clinical hypertension.
Hedner T; Persson B
Am J Hypertens; 1988 Jul; 1(3 Pt 3):317S-323S. PubMed ID: 3046635
[TBL] [Abstract][Full Text] [Related]
27. [Effectiveness of ketanserin in the treatment of light-to-moderate arterial hypertension].
Poletti L; Fogari R; Bressan MA; Poggio M; Daglio M; Ripamonti L; Vlacos D; Azzaretti G
Clin Ter; 1993 Sep; 143(3):213-7. PubMed ID: 8222552
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of action of ketanserin: studies on cardiovascular reactivity in essential and diabetes-associated hypertension.
Waser M; Ziegler WH; Beretta-Piccoli C
J Hypertens; 1988 Jun; 6(6):471-9. PubMed ID: 3411125
[TBL] [Abstract][Full Text] [Related]
29. The acute and chronic antihypertensive effects of ketanserin cannot be explained by blockade of vascular serotonin, type 2, receptors or alpha 1-adrenergic receptors.
Blauw GJ; van Brummelen P; Doorenbos CJ; van der Velde EA; van Zwieten PA
Clin Pharmacol Ther; 1991 Apr; 49(4):377-84. PubMed ID: 1849810
[TBL] [Abstract][Full Text] [Related]
30. The effect of ketanserin on blood pressure and platelets during cardiopulmonary bypass.
Lichtenthal PR; Wade LD; Rossi EC
Anesth Analg; 1987 Nov; 66(11):1151-4. PubMed ID: 3662060
[TBL] [Abstract][Full Text] [Related]
31. Novel use of continuous topical papaverine infusion delivered via a balloon pump to help maintain vascular patency in a case of intractable arterial spasm in a smoker.
Song C; Por YC; Wong CH; Woo EK
J Plast Reconstr Aesthet Surg; 2008 Aug; 61(8):988-9. PubMed ID: 18436494
[No Abstract] [Full Text] [Related]
32. Antihypertensive properties of ketanserin (R 41 468).
Vanhoutte PM; Van Nueten JM; Symoens J; Janssen PA
Fed Proc; 1983 Feb; 42(2):182-5. PubMed ID: 6295821
[TBL] [Abstract][Full Text] [Related]
33. Collateral arterial tree and responses to serotonin.
Hollenberg NK
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S35-8. PubMed ID: 2446067
[TBL] [Abstract][Full Text] [Related]
34. [Ketanserin. A new antihypertensive agent with an antagonistic effect on serotonin].
Kristensen KS; Jensen HA; Svendsen TL
Ugeskr Laeger; 1990 Mar; 152(12):837-8. PubMed ID: 2316048
[No Abstract] [Full Text] [Related]
35. The use of ketanserin for postoperative hypertension after abdominal surgery.
Shu CC; Chan KH; Lee TY; Lui PW; Daiy YP; Ma JY; Chow LH
Ma Zui Xue Za Zhi; 1990 Dec; 28(4):465-70. PubMed ID: 2097488
[TBL] [Abstract][Full Text] [Related]
36. [Clinical profile of a new antihypertensive agents. Ketanserin].
Symoens J
Rev Med Liege; 1988 Mar; 43 Suppl 1():38-49. PubMed ID: 3287546
[No Abstract] [Full Text] [Related]
37. Ageing, serotonin and ketanserin.
Breckenridge A
Drugs; 1988; 36 Suppl 1():44-54. PubMed ID: 3071462
[TBL] [Abstract][Full Text] [Related]
38. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist.
Andrén L; Svensson A; Dahlöf B; Eggertsen R; Hansson L
Acta Med Scand; 1983; 214(2):125-30. PubMed ID: 6353879
[TBL] [Abstract][Full Text] [Related]
39. Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease.
Frishman WH; Huberfeld S; Okin S; Wang YH; Kumar A; Shareef B
J Clin Pharmacol; 1995 Jun; 35(6):541-72. PubMed ID: 7665716
[TBL] [Abstract][Full Text] [Related]
40. [Role of serotonin and its receptors in the pathogenesis of arterial hypertension].
Belousov IuB; Krivonkin KIu
Kardiologiia; 1992; 32(11-12):5-9. PubMed ID: 1297881
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
